
Nov 24 (Reuters) - Novartis AG NOVN.S:
NOVARTIS AG - ITVISMA IS PRICED AT A WHOLESALE ACQUISITION COST (WAC) OF $2.59 MILLION
NOVARTIS AG - ITVISMA IS A ONE-TIME DOSE AND COST
NOVARTIS AG: EXPECT BROAD COVERAGE FOR ITVISMA & WITH OUR CO-PAY PROGRAM, ELIGIBLE PATIENTS MAY PAY AS LITTLE AS $0